Growth is expected through 2017, when the market reaches $9 billion, due to continued penetration of the population with cataracts (especially in emerging markets) as a result of efforts among national and international organizations to reduce blindness. Refractive surgeries will also contribute to revenue growth, although economic headwinds in key national markets will limit the performance of these procedures.
Other key trends, including pricing in local markets and product mix, will have key effects on competitive shares and product adoption. Critical issues covered in this report include:
Trusted By The Companies Pioneering What’s Next
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy